Altered Bone Biology in Psoriatic Arthritis
Open Access
- 17 May 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Rheumatology Reports
- Vol. 14 (4), 349-357
- https://doi.org/10.1007/s11926-012-0259-1
Abstract
Psoriatic arthritis (PsA) is characterized by focal bone erosions mediated by osteoclasts at the bone–pannus junction. The bulk of research over the past decade has centered on mechanisms that underlie osteoclastogenesis along with new insights into osteoimmunology; however, recent advances that focus on steps that lead to new bone formation are beginning to emerge. New revelations about bone formation may have direct relevance to PsA given the presence of enthesophytes, syndesmophytes, and bony ankylosis frequently observed in patients with this disorder. In this review, we discuss current developments in the pathogenesis of new bone formation, novel imaging approaches to study bone remodeling and highlight innovative approaches to study the effect of inflammation on bone. Lastly, we discuss promising therapies that target joint inflammation and osteitis with the potential to mediate pathologic bone formation.Keywords
This publication has 64 references indexed in Scilit:
- TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-JThe Journal of Experimental Medicine, 2012
- OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and miceJCI Insight, 2011
- Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infectionJCI Insight, 2011
- Role of IL-33 in inflammation and diseaseJournal of Inflammation, 2011
- Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritisArthritis Research & Therapy, 2010
- Roles of Sema4D and Plexin-B1 in tumor progressionMolecular Cancer, 2010
- Signaling cross-talk between TGF-β/BMP and other pathwaysCell Research, 2008
- The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast MaturationPublished by Elsevier BV ,2008
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destructionThe Journal of Experimental Medicine, 2006